Stratum Market Research
Request a sample

Healthcare & Life SciencesEuropean UnionUpdated 27 Oct 2026

EU MDR Compliance Market 2026: size, data and top companies

As of 28 February 2026, 52 notified bodies were designated under the EU MDR and had issued 12,036 quality-system certificates and 6,203 product certificates, per a European Commission survey. Manufacturers had lodged 31,902 applications. Legacy-device transition periods run to 31 December 2027 or 2028, and the Commission proposed simplified rules on 16 December 2025.

Edited by the Stratum Market Research editorial team. Updated 27 Oct 2026.

Headline figure

31,902applications

MDR certification applications lodged with notified bodies (to 28 Feb 2026)

Illustrative
European Commission, 2 Jul 2026

20,698 written agreements

Notified bodies and manufacturers had signed 20,698 written agreements under the MDR up to 28 February 2026.

European Commission (DG SANTE study, Gesundheit Österreich GmbH)

989 applications refused

Notified bodies had refused 989 MDR applications up to 28 February 2026.

European Commission (DG SANTE study, Gesundheit Österreich GmbH)

12,036 QMS certificates

Notified bodies had issued 12,036 MDR quality-system (QMS) certificates up to 28 February 2026, of which 6,373 were first-time.

European Commission (DG SANTE study, Gesundheit Österreich GmbH)

Why this market is moving now

  • Legacy-device transition periods end on 31 December 2027 or 2028 depending on risk class.
  • The Commission proposed simplified rules on 16 December 2025; the proposal still needs Parliament and Council adoption.
  • Only 6,203 product certificates had been issued by 28 February 2026, against 31,902 applications lodged.

Key figures

Each figure links to the page it came from.

FigureValueYearSource
Manufacturers had lodged 31,902 MDR certification applications with notified bodies from designation up to 28 February 2026.31,902 applications2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
Notified bodies and manufacturers had signed 20,698 written agreements under the MDR up to 28 February 2026.20,698 written agreements2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
Notified bodies had refused 989 MDR applications up to 28 February 2026.989 applications refused2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
Notified bodies had issued 12,036 MDR quality-system (QMS) certificates up to 28 February 2026, of which 6,373 were first-time.12,036 QMS certificates2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
Notified bodies had issued 6,203 MDR product certificates up to 28 February 2026, of which 3,291 were first-time.6,203 product certificates2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
52 notified bodies were designated for medical devices under the MDR at the time of the survey (data to 28 February 2026).52 notified bodies2026European Commission (DG SANTE study, Gesundheit Österreich GmbH)
Under Regulation (EU) 2023/607, legacy devices can benefit from a transitional period until 31 December 2027 or 31 December 2028, depending on risk class, if conditions are met.31 December 2027 / 31 December 2028 transition end dates2027European Commission
On 16 December 2025 the European Commission proposed a targeted simplification of the EU medical device rules.16 December 2025 date of proposal2025European Commission, Public Health
The MDR (Regulation (EU) 2017/745) has applied since 26 May 2021.26 May 2021 date of application2021European Commission, Public Health

What the full report covers

Illustration of a report page with its five main parts numbered12345
  1. 1

    Executive summary

    The answer on two pages: size, growth and what drives it.

  2. 2

    Market size and outlook

    History, the current year and a five-year view with base, low and high cases.

  3. 3

    Segments and regions

    Splits by product, buyer and geography across the US, Europe and MEA.

  4. 4

    Company profiles

    The main players, how they compete and where they are investing.

  5. 5

    Data and method

    Every figure in Excel, with the sources and assumptions behind it.

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the European Union market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days

Frequently asked questions

When does the EU MDR transition period end?

The European Commission's Q&A on Regulation (EU) 2023/607 says legacy devices can benefit from the transitional period until 31 December 2027 or 31 December 2028, as applicable, if conditions are met.

How many notified bodies are designated under the MDR?

The Commission's 20th notified body survey lists 52 notified bodies designated for medical devices as of data to 28 February 2026.

How many MDR certificates have been issued?

The survey counts 12,036 QMS certificates and 6,203 product certificates issued under the MDR up to 28 February 2026.

How many MDR applications have been filed?

Manufacturers had lodged 31,902 applications with notified bodies up to 28 February 2026, and 20,698 written agreements were signed.

Are the MDR rules being changed?

On 16 December 2025 the European Commission proposed a targeted simplification of the medical device rules. It must still be adopted by the European Parliament and the Council.

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)31.902
  2. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)Number of written agreements signed (from designation up to 28/02/2026) 20.698
  3. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)Number of applications refused for MDR (from designation up to 28/02/2026) 989
  4. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)Total number of QMS certificates issued for MDR (from designation up to 28/02/2026) 12.036
  5. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)Total number of product certificates issued for MDR (from designation up to 28/02/2026) 6.203
  6. European Commission (DG SANTE study, Gesundheit Österreich GmbH): Survey results of the 20th NB survey (MDR/IVDR) with data status 28 February 2026 (2026-07-02)Designated NBs for MD: 52
  7. European Commission: Extension of the MDR transitional period and removal of the 'sell off' periods: Q&A on Regulation (EU) 2023/607 (Rev. 2) (2024-07)the device benefits from the full transitional period until 31 December 2027 or 31 December 2028, as applicable
  8. European Commission, Public Health: Medical Devices - New regulations: Overview (2026)On 16 December 2025, the European Commission proposed a targeted simplification of the current rules for medical devices
  9. European Commission, Public Health: Medical Devices - New regulations: Overview (2026)With effect from 26 May 2021, Regulation (EU) 2017/745

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition